Literature DB >> 2185684

The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).

J K Field1, D A Spandidos.   

Abstract

Advances in the field of oncogenes have produced a tool to investigate the different stages in multistep carcinogenesis. The role of the ras and myc gene families have been extensively investigated in the progression of carcinogenesis in a range of human solid tumours. This review critically analyses the data available on the role of these oncogenes in the six most common cancers worldwide, (i.e. cancer of the stomach, lung, breast, colon, cervix, and mouth and pharynx). In certain cases the incidence of aberrant gene expression and genetic alterations of the ras and myc gene families have been shown to be important in the progression of these cancers and may be of use as prognostic indicators.

Entities:  

Mesh:

Year:  1990        PMID: 2185684

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  33 in total

Review 1.  Demystified ... oncogenes.

Authors:  Y L Wallis; F Macdonald
Journal:  Mol Pathol       Date:  1999-04

2.  Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max.

Authors:  K M Ryan; G D Birnie
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.

Authors:  Junqiang Tian; Hongjuan Zhao; Rosalie Nolley; Stephen W Reese; Sarah R Young; Xuejun Li; Donna M Peehl; Susan J Knox
Journal:  Clin Cancer Res       Date:  2012-04-25       Impact factor: 12.531

4.  Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line.

Authors:  Eiji Takaoka; Hiroshi Sonobe; Kunihiro Akimaru; Shuji Sakamoto; Taro Shuin; Masanori Daibata; Takahiro Taguchi; Akira Tominaga
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

5.  Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers.

Authors:  István Szanyi; Miklós Bauer; Imre Gerlinger; Tamás Járai; Gyula Gobel; László Lujber; Eva Szabadi; Katalin Fehér; Agoston Émber; István Ember; István Kiss
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-01       Impact factor: 2.503

6.  Repression of cyclin D1: a novel function of MYC.

Authors:  A Philipp; A Schneider; I Väsrik; K Finke; Y Xiong; D Beach; K Alitalo; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.

Authors:  M Volm; P Drings; W Wodrich
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Protein tyrosine (de-)phosphorylation in head and neck squamous cell carcinoma.

Authors:  H P Verschuur; G Rijksen; B A van Oirschot; G P Schipper-Kester; P J Slootweg; G E Staal; G J Hordijk
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

9.  Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-01

10.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.